WHO ICTRP trial
Tresiba injection in the morning or evening trial
JPRN-UMIN000024077 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000024077 |
|---|---|
| Public title | Tresiba injection in the morning or evening trial |
| Scientific title | Tresiba injection in the morning or evening trial - TIME trial |
| Primary sponsor | Kumamoto university |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Type 2 diabetes |
| Interventions | injection of insulin degludec in the morning injection of insulin degludec in the evening |
| Registration date | Jan 10, 2016 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: